Geode Capital Management’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.1M | Buy |
1,704,394
+22,003
| +1% | +$247K | ﹤0.01% | 1982 |
|
|
2025
Q1 | $7.69M | Buy |
1,682,391
+56,611
| +3% | +$259K | ﹤0.01% | 2446 |
|
|
2024
Q4 | $9.17M | Buy |
1,625,780
+25,093
| +2% | +$142K | ﹤0.01% | 2432 |
|
|
2024
Q3 | $7.75M | Buy |
1,600,687
+40,915
| +3% | +$198K | ﹤0.01% | 2516 |
|
|
2024
Q2 | $7.61M | Buy |
1,559,772
+110,346
| +8% | +$539K | ﹤0.01% | 2490 |
|
|
2024
Q1 | $19.3M | Buy |
1,449,426
+319,263
| +28% | +$4.24M | ﹤0.01% | 1954 |
|
|
2023
Q4 | $15.8M | Buy |
1,130,163
+77,283
| +7% | +$1.08M | ﹤0.01% | 2056 |
|
|
2023
Q3 | $14M | Buy |
1,052,880
+96,153
| +10% | +$1.28M | ﹤0.01% | 2054 |
|
|
2023
Q2 | $17.9M | Buy |
956,727
+70,956
| +8% | +$1.33M | ﹤0.01% | 1921 |
|
|
2023
Q1 | $12.8M | Buy |
885,771
+38,038
| +4% | +$549K | ﹤0.01% | 2101 |
|
|
2022
Q4 | $16.4M | Buy |
847,733
+65,021
| +8% | +$1.26M | ﹤0.01% | 1908 |
|
|
2022
Q3 | $26.9M | Buy |
782,712
+315,492
| +68% | +$10.8M | ﹤0.01% | 1531 |
|
|
2022
Q2 | $7.14M | Buy |
467,220
+40,952
| +10% | +$626K | ﹤0.01% | 2480 |
|
|
2022
Q1 | $9.73M | Buy |
426,268
+135,800
| +47% | +$3.1M | ﹤0.01% | 2359 |
|
|
2021
Q4 | $10.7M | Buy |
290,468
+15,664
| +6% | +$578K | ﹤0.01% | 2399 |
|
|
2021
Q3 | $12.9M | Buy |
274,804
+242,702
| +756% | +$11.4M | ﹤0.01% | 2277 |
|
|
2021
Q2 | $1.93M | Buy |
+32,102
| New | +$1.93M | ﹤0.01% | 3276 |
|